Direct Meds GLP-1 vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Direct Meds GLP-1 beats MEDVi overall, scoring 7.9/10 vs 7.7/10. Direct Meds GLP-1 is more affordable at $297/mo vs $299/mo. Choose Direct Meds GLP-1 for users wanting simple, all-inclusive pricing without insuranc. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Direct Meds GLP-1 and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Direct Meds GLP-1

#13 of 48

7.9/10

Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.

Visit Direct Meds GLP-1

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Direct Meds GLP-1	MEDVi
Our Score	7.9/10	7.7/10
Starting Price	$297/mo	$299/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Users wanting simple, all-inclusive pricing without insurance	Users who want a low entry price with oral and injectable compounded options
Ranking	#13	#22

Pros & Cons Compared

Direct Meds GLP-1

Pros

+True all-inclusive pricing — $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
+Clear dose-based pricing published on their site — no surprise cost increases when titrating up
+Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
+Responsive customer support with live chat available during business hours

Cons

−Compounded medications only — cannot prescribe brand-name Wegovy, Zepbound, or Ozempic
−At $280/mo for compounded-only, it's pricier than competitors like Henry Meds ($199) or TrimRx ($179)

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

Direct Meds GLP-1 edges out MEDVi with a score of 7.9/10 vs 7.7/10. If budget is your priority, Direct Meds GLP-1 starts at $297/mo compared to MEDVi's $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Direct Meds GLP-1 nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review